|
All international travelers should be fully vaccinated against measles with the measles-mumps-rubella (MMR) vaccine, including an early dose for infants 6–11 months, according to CDC’s measles vaccination recommendations for international travel.
CDC Travel Notices
The American Academy of Pediatrics has published a report that goes over how to talk with parents and caregivers about vaccines. This tool is offered to assist with improving vaccination rates. The full report can be found here: Strategies for Improving Vaccine Communication and Uptake. The AAP has also developed a reference document called Think Measles which provides tips to identifying measles in practice.
Please also see the following resources for more information:
Clinical Resources: Measles
Measles One-Pager
|
The Maine Immunization Program's federal vaccine distribution program, VTrckS, has scheduled a maintenance downtime. Any orders placed after 2:00 PM on March 21 will not ship until April 1.
Please place orders accordingly to ensure you have enough inventory on hand.
On March 5th, the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) met to discuss the selection of influenza variants to be included in next season's vaccines. Data presented supported a trivalent vaccine versus the current quadrivalent vaccines being administered. The change comes at the discovery that the b/Yamagata influenza strain has been absent in circulation since 2020.
VRBPAC voted to eliminate the B/Yamagata influenza strain from the upcoming season’s influenza vaccine, making the vaccines a trivalent (H1N1, H1N2, and B/Victoria lineage strains).
For more information, please visit:
Use of Trivalent Influenza Vaccines for the 2024-2025 U.S. Influenza Season
FDA Vaccines and Related Biological Products Advisory Committee March 5, 2024 Meeting Announcement
Pfizer has changed the diluent pack size associated with VFC orders of Pfizer COVID-19 vaccine (2023-2024 Formula) for ages 6 months through 4 years of age. Previously, vaccine orders for this presentation were supplied with diluent in a 10-pack. Pfizer will now supply diluent in a 25-pack. Diluent will be provided in quantities so that providers receive sufficient diluent to administer all doses of vaccines ordered. As a reminder, one vial of diluent is required to reconstitute one multi-dose vial of vaccine for individuals 6 months through 4 years of age. Questions about diluent received with Pfizer COVID-19 Vaccine (2023-2024 Formula) for ages 6 months through 4 years of age can be directed to Pfizer customer service at: 1-800-666-7248, Option 2 or mrnavaccines@pfizer.com |
